Sei Investments Co. Buys 240 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Sei Investments Co. grew its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 0.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 208,590 shares of the company’s stock after buying an additional 240 shares during the period. Sei Investments Co. owned 0.42% of Prestige Consumer Healthcare worth $16,289,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Intech Investment Management LLC bought a new stake in shares of Prestige Consumer Healthcare during the 3rd quarter valued at about $620,000. Citigroup Inc. increased its stake in Prestige Consumer Healthcare by 66.6% in the 3rd quarter. Citigroup Inc. now owns 76,772 shares of the company’s stock worth $5,535,000 after purchasing an additional 30,677 shares during the period. Cerity Partners LLC increased its stake in shares of Prestige Consumer Healthcare by 103.9% in the third quarter. Cerity Partners LLC now owns 6,347 shares of the company’s stock worth $458,000 after buying an additional 3,234 shares during the period. BNP Paribas Financial Markets increased its position in shares of Prestige Consumer Healthcare by 276.2% in the third quarter. BNP Paribas Financial Markets now owns 17,379 shares of the company’s stock valued at $1,253,000 after acquiring an additional 12,759 shares during the period. Finally, Townsquare Capital LLC raised its position in Prestige Consumer Healthcare by 8.8% during the 3rd quarter. Townsquare Capital LLC now owns 77,168 shares of the company’s stock valued at $5,564,000 after purchasing an additional 6,249 shares during the last quarter. 99.95% of the stock is owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Trading Down 1.2 %

PBH stock opened at $85.01 on Friday. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20. The company has a market capitalization of $4.21 billion, a price-to-earnings ratio of 19.91, a PEG ratio of 2.69 and a beta of 0.46. The business has a 50 day simple moving average of $83.30 and a two-hundred day simple moving average of $78.97. Prestige Consumer Healthcare Inc. has a 1-year low of $62.35 and a 1-year high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings data on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. Research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

PBH has been the subject of several research reports. Canaccord Genuity Group upped their price objective on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a report on Friday, February 7th. Sidoti lowered Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price target for the company. in a research report on Monday, December 9th. DA Davidson increased their price target on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a report on Friday, February 7th. Raymond James upgraded shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research note on Thursday, December 19th. Finally, StockNews.com upgraded Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Tuesday, March 18th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, Prestige Consumer Healthcare presently has a consensus rating of “Moderate Buy” and a consensus price target of $93.33.

Insider Buying and Selling

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of Prestige Consumer Healthcare stock in a transaction on Monday, March 10th. The shares were sold at an average price of $90.00, for a total transaction of $151,020.00. Following the completion of the transaction, the senior vice president now directly owns 17,157 shares of the company’s stock, valued at $1,544,130. The trade was a 8.91 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.60% of the stock is currently owned by company insiders.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.